Response to: 'Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?' by Teng et al

Affiliations

¹ Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine at the TU Dresden, Dresden, Germany martin.aringer@uniklinikum-dresden.de.
² Division of Rheumatology and Immunology, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
⁴ Division of Rheumatology, Department of Medicine, Toronto Western Hospital, Mount Sinai Hospital; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Free article

Comment

Martin Aringer et al. Ann Rheum Dis. 2022 Feb.

Free article

. 2022 Feb;81(2):e23.

doi: 10.1136/annrheumdis-2020-217105. Epub 2020 Mar 2.

¹ Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine at the TU Dresden, Dresden, Germany martin.aringer@uniklinikum-dresden.de.
² Division of Rheumatology and Immunology, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
⁴ Division of Rheumatology, Department of Medicine, Toronto Western Hospital, Mount Sinai Hospital; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

No abstract available

Keywords: autoantibodies; disease activity; systemic lupus erythematosus.

Conflict of interest statement

Competing interests: None declared.

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. Aringer M, et al. Ann Rheum Dis. 2019 Sep;78(9):1151-1159. doi: 10.1136/annrheumdis-2018-214819. Epub 2019 Aug 5. Ann Rheum Dis. 2019. PMID: 31383717 Review.
Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?
Teng J, Zhou Z, Wang F, Sun Y, Liu HL, Cheng X, Su Y, Shi H, Yang C, Ye J. Teng J, et al. Ann Rheum Dis. 2022 Feb;81(2):e22. doi: 10.1136/annrheumdis-2020-217017. Epub 2020 Mar 2. Ann Rheum Dis. 2022. PMID: 32122908 No abstract available.